Dysregulation of this IRES-mediated translation in distinct transcripts, such as insulin-like growth factor 1 (IGF-1) receptor, are implicated under certain conditions with the corresponding pathology, i.e., diabetes (as suggested in Marques et al. 55), pointing towards the clinical relevance of this pathway. This evidence concerns the gene IGF1 and diabetes mellitus.